Podcast

Listen to the latest episode of the ASBMB's science policy podcast with Public Affairs Director Benjamin Corb.

Find all of the Pipettes & Politics episodes on Soundcloud, or subscribe wherever you get your podcasts.

Survey

Remote study sections

The coronavirus pandemic has forced federal agencies to move study sections to virtual settings, allowing reviews to continue while also allowing reviewers to follow federal guidance restricting travel and personal interactions.

In an effort to measure and understand the impact that remote peer review might have on science (positive or negative) the ASBMB encourages you to take a moment and share your thoughts and experiences regarding online study sections.

ASBMB Today
AeroNabs promise powerful, inhalable protection against COVID-19

As the world awaits vaccines to bring the COVID-19 pandemic under control, UC San Francisco scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.

Why hydroxychloroquine and chloroquine don't block coronavirus infection of human lung cells

Scientists in Germany tested the malaria drugs on various cell types and found they can block coronavirus infection in kidney cells from the African green monkey but don’t inhibit the virus in human lung cells.

The color of COVID

In a summer dominated by COVID-19 and protests against racial injustice, there are growing demands that drugmakers and investigators ensure that vaccine trials reflect the entire community.

Developing an effective COVID-19 vaccine

Our bodies have two main types of T cells. Together they can help us fend off this virus

What are the advantages of an mRNA vaccine for COVID-19?

They’re easier to manufacture than traditional vaccines, but scientifically their history is checkered

NIH project homes in on COVID racial disparities

Amid a wavering federal response that has allowed staggering levels of disease to sweep the country, the All of Us program is a potential bright spot.

The time of trials: Waiting for a coronavirus vaccine

An infected and impatient world needs protection from Covid-19, but rushing it won't be easy. How can we speed up a complicated process?

We are here because we choose to be

Five months into a pandemic with arguably the world’s worst response, the United States can no longer take the easy way out and blame only politics for our downfall. We’re to blame, too.

How 'good' does a COVID-19 vaccine need to be?

New study finds that a coronavirus vaccine’s effectiveness may have to be higher than 70% or even 80% before Americans can safely stop relying on social distancing.

COVID-19 retractions show that the science is working as it should

Severe scrutiny of two major papers, including one about the effectiveness of hydroxychloroquine, is part of science's normal process of self-correction, explains Mark R. O’Brian.

How can labs reopen safely?

Labs are trying to reopen and get back to research while not spreading COVID-19. Great goal, but how do we do that?

Resources from the ASBMB

thumbnail

COVID-19 resources and guidance from funding agencies

See our list of guidance and resources from the NSF, NIH, DOE and others.

thumbnail

Online teaching: Practices and resources

A collection of resources for instructors in biochemistry, molecular biology and related fields as they make a transition to remote learning.

thumbnail
Magazine

Slipping past the proofreader

The virus that causes COVID-19 has its own superpower. Can new drug candidates overcome it?

thumbnail
Virtual event

The cost of the COVID-19 pandemic

The COVID-19 pandemic has had a significant impact on the scientific community by halting research and concentrating scientific resources on endeavors to better understand the SARS-CoV-2 virus.

thumbnail
Virtual event

COVID-19 interruptions to NIH research

Understanding the funding implications and relief options of the recently passed CARES Act for the scientific community.

thumbnail
Virtual event

Shaping the Narrative: Effective science communication in the COVID-19 era

A panel discussion about how scientists can use their credibility and critical thinking to cut through the noise and guide the national COVID-19 dialogue.

Other resources

COVID-19 resources for librarians, campuses and health professionals
Access to coronavirus research, textbooks, text and data mining, and clinical information from Elsevier.

Sharing, discovering and citing COVID-19 data and code
A webinar from the NIH.

Open-access data and computational resources to address COVID-19
NIH curated list of links to data sources.

Virtual NIH activities for trainees outside the NIH
Resources from the NIH Office of Intramural Training & Education, including online workshops.

TED Connects
Daily conversations with TED talkers.

Resources from the Council of Graduate Schools for navigating the COVID-19 pandemic

Discussions on the biomedical workforce in the time of COVID-19
A series of discussions hosted by Rescuing Biomedical Research.

Journal of Biological Chemistry
JBC

Coronaviruses

JBC's coronavirus virtual issue presents a retrospective collection of content on coronavirus entry, proteases and host interactions to help researchers build more quickly toward therapeutic endpoints against SARS-CoV-2 and future strains.

See also...
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus